Genomics Analysis Report
: Analysis on the Market, Trends, and TechnologiesThe Genomics Analysis domain has a strong presence in the biotechnology, healthcare, and research industries. Despite a slight decline in growth rates, the domain continues to attract significant investments and media attention, demonstrating resilience and potential for future expansion. Companies are actively engaged in various applications of genomics, including microbial genomics, cancer detection, and personalized healthcare, supported by advancements in next-generation sequencing, bioinformatics, and AI-driven analysis.
We updated this report 459 days ago. Missing information? Contact us to add your insights.
Topic Dominance Index of Genomics Analysis
The Topic Dominance Index combines the distribution of news articles that mention Genomics Analysis, the timeline of newly founded companies working within this sector, and the share of voice within the global search data
Key Activities and Applications
- Microbial Genomics: Understanding microbial communities for ecosystem and host health.
- Cancer Diagnostics: Development of mRNA-based diagnostics for cancer detection and monitoring.
- Personalized Healthcare: Bridging gaps between rare disease communities and researchers, with platforms for personalized treatment.
- Genomic Data Analysis: Providing bioinformatics services for genomics data analysis, including transcriptomics and metagenomics.
- Agricultural Genomics: Enhancing crop care and agricultural productivity through genomic technologies.
Emergent Trends and Core Insights
- AI and Machine Learning: Integration of AI to predict adverse drug reactions and enhance genomics data interpretation.
- Cloud Computing: Adoption of cloud-based systems for scalable and accessible genomic analysis.
- Personalized Medicine: Focus on individualized diagnostics and treatments based on genomic data.
- Investment and Funding: Continued financial backing, indicating confidence in the genomics analysis market.
Technologies and Methodologies
- Next-Generation Sequencing (NGS): Key technology for high-throughput genomic analysis.
- Bioinformatics Platforms: Development of platforms for efficient management and interpretation of genomic data.
- Data Analytics: Use of big data analytics for genomics to drive precision medicine.
- Microfluidics and Nanotechnology: Innovations in sample processing and DNA sequencing.
Genomics Analysis Funding
A total of 88 Genomics Analysis companies have received funding.
Overall, Genomics Analysis companies have raised $1.8B.
Companies within the Genomics Analysis domain have secured capital from 229 funding rounds.
The chart shows the funding trendline of Genomics Analysis companies over the last 5 years
Genomics Analysis Companies
Gain a competitive edge with access to 244 Genomics Analysis companies.
244 Genomics Analysis Companies
Discover Genomics Analysis Companies, their Funding, Manpower, Revenues, Stages, and much more
Genomics Analysis Investors
Leverage TrendFeedr’s sophisticated investment intelligence into 71 Genomics Analysis investors. It covers funding rounds, investor activity, and key financial metrics in Genomics Analysis. investors tool is ideal for business strategists and investment experts as it offers crucial insights needed to seize investment opportunities.
71 Genomics Analysis Investors
Discover Genomics Analysis Investors, Funding Rounds, Invested Amounts, and Funding Growth
Genomics Analysis News
TrendFeedr’s News feature provides a historical overview and current momentum of Genomics Analysis by analyzing 1.1K news articles. This tool allows market analysts and strategists to align with latest market developments.
1.1K Genomics Analysis News Articles
Discover Latest Genomics Analysis Articles, News Magnitude, Publication Propagation, Yearly Growth, and Strongest Publications
Executive Summary
The Genomics Analysis business domain is a vibrant and evolving landscape, marked by the integration of advanced technologies like AI, NGS, and cloud computing. These advancements are propelling the industry forward, enabling personalized medicine, and attracting significant investments. The trend's resilience, despite a slight decline in growth rates, is indicative of its potential for further development and its critical role in shaping the future of healthcare and biotechnology.
Interested in contributing your expertise on trends and tech? We’d love to hear from you.
